Through innovative R&D in nanomedicine, we seek to restore freedom, happiness, and the ability to live fully to those affected by cancer.
The formulation is engineered for biocompatibility and biodegradability through a 16-step advanced nanoprocessing process.
Onselex has built a broad intellectual property portfolio covering its nanoparticle platform and potential applications.
Onselex is expanding its pipeline by developing innovative and effective new drugs.
Pancreatic/liver cancer treatment
Ovarian cancer
Stomach/Colon cancer (pills)
Company History
Leadership
Onselex may pursue strategic partnerships with global pharmaceutical companies as needed, including opportunities for co-development, licensing, and commercialization.
Freedom, happiness, and a return to normal life.